Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -279,381 | -172,871 | -173,482 | -118,476 | -78,253 |
| Depreciation Amortization | 1,269 | 615 | -31 | 143 | 522 |
| Other Working Capital | -19,757 | 25,372 | 27,666 | 8,569 | 8,777 |
| Other Operating Activity | 83,362 | 14,078 | 16,922 | 16,004 | 7,367 |
| Operating Cash Flow | $-214,507 | $-132,806 | $-128,925 | $-93,760 | $-61,587 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,153 | -587 | 1,270 | -8,206 | 29,500 |
| PPE Investments | -357 | -131 | -90 | -2 | -344 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -15,200 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 12,589 |
| Investing Cash Flow | $-24,510 | $-718 | $1,180 | $-8,208 | $26,545 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 29,987 | N/A | N/A | N/A |
| Common Stock Issued | 679,827 | 175,021 | 113,639 | 133,659 | 5,029 |
| Other Financing Activity | 0 | -795 | 0 | 0 | -13 |
| Financing Cash Flow | $679,827 | $204,213 | $113,639 | $133,659 | $5,016 |
| Beginning Cash Position | 113,888 | 43,199 | 57,305 | 25,614 | 55,640 |
| End Cash Position | 554,698 | 113,888 | 43,199 | 57,305 | 25,614 |
| Net Cash Flow | $440,810 | $70,689 | $-14,106 | $31,691 | $-30,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | -214,507 | -132,806 | -128,925 | -93,760 | -61,587 |
| Capital Expenditure | -357 | -131 | -90 | -2 | -344 |
| Free Cash Flow | -214,864 | -132,937 | -129,015 | -93,762 | -61,931 |